Skip to main content
Industry News
FDA adds antidepressant Zoloft to shortage list
6/2/2020

The FDA added Pfizer's antidepressant drug Zoloft and generic sertraline to the list of drugs in short supply amid a spike in demand as the pandemic takes a toll on mental health. Generic-drug companies that make sertraline said they have had difficulty securing enough of the active pharmaceutical ingredient used to make the drug, while Pfizer makes its own API but said some bottles and formulations are in short supply.

Full Story: